Baird Medical Investment Holdings Ltd
BDMD0.920USD
+0.016+1.74%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
24.44MMarket Cap
LossP/E TTM
More Details of Baird Medical Investment Holdings Ltd Company
Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.
Baird Medical Investment Holdings Ltd Info
Ticker SymbolBDMD
Company nameBaird Medical Investment Holdings Ltd
IPO dateDec 13, 2021
CEOWu (Haimei)
Number of employees143
Security typeOrdinary Share
Fiscal year-endDec 13
Address18/F, Ovest
CityGUANGZHOU
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code- -
Phone
Websitehttps://ir.bairdmed.com/
Ticker SymbolBDMD
IPO dateDec 13, 2021
CEOWu (Haimei)
Company Executives of Baird Medical Investment Holdings Ltd
Name
Name/Position
Position
Shareholding
Change
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
+18295281.00%
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Ms. Quan Qiu
Ms. Quan Qiu
Chief Administrative Officer, Director
Chief Administrative Officer, Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Ms. Gabrielle Bilciu-Wolfson
Ms. Gabrielle Bilciu-Wolfson
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Jianwei Yuan
Mr. Jianwei Yuan
Production Department Manager
Production Department Manager
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
+18295281.00%
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Ms. Quan Qiu
Ms. Quan Qiu
Chief Administrative Officer, Director
Chief Administrative Officer, Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
By BusinessUSD
Name
Revenue
Proportion
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
37.04M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Shareholding Stats
Updated: Sat, Jan 3
Updated: Sat, Jan 3
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wu (Haimei)
49.82%
ExcelFin SPAC LLC
13.00%
Grand Fortune Capital (H.K.) Co, Ltd.
6.71%
Periscope Capital
0.34%
Highbridge Capital Management, LLC
0.34%
Other
29.79%
Shareholders
Shareholders
Proportion
Wu (Haimei)
49.82%
ExcelFin SPAC LLC
13.00%
Grand Fortune Capital (H.K.) Co, Ltd.
6.71%
Periscope Capital
0.34%
Highbridge Capital Management, LLC
0.34%
Other
29.79%
Shareholder Types
Shareholders
Proportion
Individual Investor
49.82%
Corporation
19.71%
Investment Advisor/Hedge Fund
0.54%
Hedge Fund
0.47%
Investment Advisor
0.09%
Research Firm
0.04%
Other
29.34%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
34
465.80K
9.90%
--
2025Q3
47
465.80K
18.84%
-72.37K
2025Q2
50
538.17K
21.64%
+180.74K
2025Q1
80
357.43K
67.10%
-16.79M
2024Q4
85
305.49K
75.32%
+42.45K
2024Q3
88
263.04K
299.72%
-979.92K
2024Q2
90
1.24M
285.03%
-389.76K
2024Q1
94
1.63M
272.11%
-20.00M
2023Q4
94
1.73M
289.40%
-2.99M
2023Q3
93
4.71M
469.75%
-226.48K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wu (Haimei)
18.30M
68.9%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
17.98%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.28%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.47%
--
--
Sep 30, 2025
Highbridge Capital Management, LLC
125.00K
0.47%
--
--
Sep 30, 2025
Northern Trust Investments, Inc.
48.29K
0.18%
-4.15K
-7.92%
Sep 30, 2025
Citadel Advisors LLC
46.53K
0.18%
+46.53K
--
Sep 30, 2025
UBS Financial Services, Inc.
65.82K
0.25%
-25.63K
-28.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
25.44K
0.1%
--
--
Sep 30, 2025
Virtu Americas LLC
14.04K
0.05%
-12.32K
-46.73%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
